Crest Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 5.80 Cr
as on 20-12-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.67 Cr
as on 20-12-2024
- Satisfied Charges ₹ 12.27 Cr
as on 20-12-2024
- Revenue 29.89%
(FY 2022)
- Profit -1231.42%
(FY 2022)
- Ebitda -247.61%
(FY 2022)
- Net Worth -157.73%
(FY 2022)
- Total Assets -2.38%
(FY 2022)
About Crest Lifesciences
The Corporate was formerly known as Crest Lifesciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.80 Cr.
The company currently has active open charges totaling ₹28.67 Cr. The company has closed loans amounting to ₹12.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raj Khatuwala, Sunil Agarwal, and Shilpa Sahi serve as directors at the Company.
- CIN/LLPIN
U24130HP2015PTC000969
- Company No.
000969
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Crest Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Khatuwala  | Director | 09-Jul-2022 | Current |
| Sunil Agarwal | Director | 09-Jul-2022 | Current |
| Shilpa Sahi | Director | 17-Apr-2023 | Current |
Financial Performance and Corporate Structure Insights of Crest Lifesciences.
Crest Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.89% increase. The company also saw a substantial fall in profitability, with a 1231.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 157.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crest Lifesciences?
In 2021, Crest Lifesciences had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Crest Topicals Private LimitedActive 10 years 5 daysRaj Khatuwala and Sunil Agarwal are mutual person
Crest Healthcare Private LimitedActive 19 years 5 monthsRaj Khatuwala and Sunil Agarwal are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Nov 2024 | ₹18.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Jan 2023 | ₹10.67 Cr | Open |
Yes Bank Limited Creation Date: 15 Jan 2020 | ₹7.34 Cr | Satisfied |
How Many Employees Work at Crest Lifesciences?
Crest Lifesciences has a workforce of 42 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crest Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crest Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
